| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA688693 | F | In vitro cytotoxic activity against HL-60 human leukemia cell line by MTT assay (microculture terazolium colorimetric) | Homo sapiens | 9 | ALA1131984 | cell-based format | Scientific Literature | |
| 2. | ALA715526 | F | Ratio of the body weight of mice at the initial stage and the final stage of the experiment was reported at a dose of 10 mg/kg (Q2dx10) administered i.p.; 18.7/16.0 | Mus musculus | 1 | ALA1131984 | organism-based format | Scientific Literature | |
| 3. | ALA715527 | F | Ratio of the body weight of mice at the initial stage and the final stage of the experiment was reported at a dose of 10 mg/kg (Q2dx10) administered i.p.; 19.6/21.3 | Mus musculus | 1 | ALA1131984 | organism-based format | Scientific Literature | |
| 4. | ALA715528 | F | Ratio of the body weight of mice at the initial stage and the final stage of the experiment was reported at a dose of 10 mg/kg (Q2dx10) administered i.p.; 21.8/19.5 | Mus musculus | 1 | ALA1131984 | organism-based format | Scientific Literature | |
| 5. | ALA715529 | F | Ratio of the body weight of mice at the initial stage and the final stage of the experiment was reported at a dose of 10 mg/kg (Q2dx10) administered i.p.; 22.0/22.6 | Mus musculus | 1 | ALA1131984 | organism-based format | Scientific Literature | |
| 6. | ALA715530 | F | Ratio of the body weight of mice at the initial stage and the final stage of the experiment was reported at a dose of 10 mg/kg (Q2dx10) administered i.p.; 24.8/26.0 | Mus musculus | 1 | ALA1131984 | organism-based format | Scientific Literature | |
| 7. | ALA715531 | F | Ratio of the body weight of mice at the initial stage and the final stage of the experiment was reported at a dose of 10 mg/kg (Q2dx9) administered i.p.; 21.1/24.6 | Mus musculus | 1 | ALA1131984 | organism-based format | Scientific Literature | |
| 8. | ALA715532 | F | Ratio of the body weight of mice at the initial stage and the final stage of the experiment was reported at a dose of 15 mg/kg i.p. (day 9); 19.0/16.6 | Mus musculus | 1 | ALA1131984 | organism-based format | Scientific Literature | |
| 9. | ALA878354 | F | Ratio of the body weight of mice at the initial stage and the final stage of the experiment was reported at a dose of 15 mg/kg i.p. (day 9); 19.9/18.3 | Mus musculus | 1 | ALA1131984 | organism-based format | Scientific Literature | |
| 10. | ALA713810 | F | Ratio of the body weight of mice at the initial stage and the final stage of the experiment was reported at a dose of 15 mg/kg i.p. (day 6); 20.9/22.8 | Mus musculus | 1 | ALA1131984 | organism-based format | Scientific Literature | |
| 11. | ALA713811 | F | Ratio of the body weight of mice at the initial stage and the final stage of the experiment was reported at a dose of 15 mg/kg (day 6); 21.4/20.4 | Mus musculus | 1 | ALA1131984 | organism-based format | Scientific Literature | |
| 12. | ALA713812 | F | Ratio of the body weight of mice at the initial stage and the final stage of the experiment was reported at a dose of 15 mg/kg (day 6); 21.7/21.0 | Mus musculus | 1 | ALA1131984 | organism-based format | Scientific Literature | |
| 13. | ALA714503 | F | Ratio of the body weight of mice at the initial stage and the final stage of the experiment was reported at a dose of 20 mg/kg (Q2dx10) administered i.p.; 18.5/19 | Mus musculus | 1 | ALA1131984 | organism-based format | Scientific Literature | |
| 14. | ALA714504 | F | Ratio of the body weight of mice at the initial stage and the final stage of the experiment was reported at a dose of 20 mg/kg (Q2dx10) administered i.p.; 19.5/19.9 | Mus musculus | 1 | ALA1131984 | organism-based format | Scientific Literature | |
| 15. | ALA714673 | F | Ratio of the body weight of mice at the initial stage and the final stage of the experiment was reported at a dose of 20 mg/kg (Q2dx10) administered i.p.; 22.3/21.2 | Mus musculus | 1 | ALA1131984 | organism-based format | Scientific Literature | |
| 16. | ALA714674 | F | Ratio of the body weight of mice at the initial stage and the final stage of the experiment was reported at a dose of 20 mg/kg (Q2dx10) administered i.p.; 22.3/23.5 | Mus musculus | 1 | ALA1131984 | organism-based format | Scientific Literature | |
| 17. | ALA714675 | F | Ratio of the body weight of mice at the initial stage and the final stage of the experiment was reported at a dose of 20 mg/kg (Q2dx10) administered i.p.; 24.5/25.0 | Mus musculus | 1 | ALA1131984 | organism-based format | Scientific Literature | |
| 18. | ALA714676 | F | Ratio of the body weight of mice at the initial stage and the final stage of the experiment was reported at a dose of 20 mg/kg (Q2dx9) administered i.p.; 21.4/23.0 | Mus musculus | 1 | ALA1131984 | organism-based format | Scientific Literature | |
| 19. | ALA714680 | F | Ratio of the body weight of mice at the initial stage and the final stage of the experiment was reported at a dose of 3.75 mg/kg (day 10) administered i.p.; 19.2/20.5 | Mus musculus | 1 | ALA1131984 | organism-based format | Scientific Literature | |
| 20. | ALA714681 | F | Ratio of the body weight of mice at the initial stage and the final stage of the experiment was reported at a dose of 3.75 mg/kg (day 7); 21.4/23.8 | Mus musculus | 1 | ALA1131984 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!